Month: March 2012

Three of every four drug addicts suffer from dual pathology ”. 20th update course in psychiatry. Vitoria, March 2012. -The dual pathology ” consists of the presence in a person of an addiction to a substance and a psychiatric disorder such as schizophrenia or psychosis -this disease is a major health and social problem -recognition and management is difficult for mental health and addiction services Vitoria-Gasteiz, March 2012.- the relationship between drug use and psychiatric disorders is very close. 72% Of drug addicts suffer from dual pathology ”. This disease is the existence in one person of an addiction to alcohol or other drugs such as cannabis or cocaine, and a historical such as schizophrenia or psychosis disorder. These statements were made by the President of the Spanish society of Dual pathology (EDPS), Dr. Nestor Szerman, at the Conference dual Pathology: a problem of our time. why now, and not before? ” the 20th update course in psychiatry held in Vitoria. The most commonly used in this type of patient substance is alcohol, followed by marijuana and cocaine. Medications that require a prescription, such as tranquilizers and sleeping pills are also included. Drug addiction is a consequence of gross mental illness or previous vulnerabilities of the individual that make that mental illnesses that may not have manifested itself can trigger. Addictions include not only substances (drugs), but also the...

AELMHU chosen as one of the best initiatives of the pharmacy of the year. Madrid, March 2012.- the Association Spanish laboratories of medicines orphans and Ultra-Huérfanos (AELMHU) has received, for its creation about a year ago, one of the prizes for the best initiative of the pharmacy of the year in the category best project Solidario and patronageorganized by mail pharmacist. AELMHU is an association non-profit formed by several pharmaceutical companies engaged in trying to improve the situation of patients with rare diseases through investment in the discovery and development of innovative therapies. Mail pharmacist has awarded this Association because they help to improve the world of pharmacy, pharmaceutical care and health with his creation. Recognition as these motivate us to continue to meet our objectives and increase, thus knowledge about rare and ultra-raras diseases ”, expresses Juan Ferrero, President of AELMHU. The Association aims main stimulate the assessment of medicines orphans and ultra-huérfanos, promote actions that recognize the value of this type of treatment and therapeutic and keep its members coordinated their actions to the social and governmental institutions. Also, AELMHU intends to constantly maintain activities to facilitate the rapid and equitable access to medicines orphans and ultra-huérfanos for all those affected; enable spaces for collaboration with the medical and health, areas as well as the scientific community, with regard to the promotion of knowledge and the benefits...